Assessment of awareness of pre-exposure prophylaxis methods against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers
- 作者: Kuimova U.A.1, Belyaeva V.V.1, Kozyrina N.V.1, Kulabukhova E.I.2, Goliusova M.D.1, Kuimova I.V.3
-
隶属关系:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Peoples' Friendship University of Russia
- Novosibirsk State Medical University
- 期: 卷 12, 编号 3 (2022)
- 页面: 54-58
- 栏目: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287958
- DOI: https://doi.org/10.18565/epidem.2022.12.3.54-58
- ID: 287958
如何引用文章
详细
全文:
作者简介
Ulyana Kuimova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: ulyanakuimova@gmail.com
Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology
Valentina Belyaeva
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: labora-et-ora@yandex.ru
МD, Leading Researcher
Nadezhda Kozyrina
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Senior Researcher
Ekaterina Kulabukhova
Peoples' Friendship University of Russia
Email: ekulabukhova@mail.ru
Cand. Med. Sci., Infectiologist
Marina Goliusova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: mad2501@yandex.ru
Infectiologist, Central Research Institute of Epidemiology
Irina Kuimova
Novosibirsk State Medical University
Email: kuimova_ira@mail.ru
МD, Professor, Department of Infectious Diseases
参考
- Holmes D. FDA paves the way for pre-exposure HIV prophylaxis. Lancet 2012; 380: 325.
- Hodges-Mameletzis I., Dalal S., Msimanga-Radebe B., Rodolph M., Baggaley R. Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health 2018; 15(6): 489-500. doi: 10.1071/SH18125
- Anderson P., Glidden D.V., Liu A., Buchbinder S., Lama J.R., Cuaniro J. et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci. Transl. Med. 2012; 4(151): 151ra125. doi: 10.1126/scitranslmed.3004006
- Molina J.M., Capitant С., Spire B., Pialoux G., Chidiac C., Charreau I. et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. CROI 2015. 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015), 23-26 February 2015. Seattle, Washington, USA. Oral late breaker abstract 23LB. http://www.croiconference.org/sessions/demand-prep-oral-tdf-ftc-msm-results-anrs-ipergay-trial
- PrEP for HIV Prevention in the U.S. https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html
- FDA NEWS RELEASE. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
- Ефремова О.С., Беляева В.В., Козырина Н.В., Куимова У.А., Покровская А.В., Суворова З.К. Оценка информированности ВИЧ-инфицированных пациентов о методике доконтактной профилактики, отношения к ее проведению и перспектив проведения в России. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; 10(3): 99-104. https://dx.doi.org/10.18565/epidem.2020.10.3.99-104
- Беляева В.В., Козырина Н.В., Куимова У.А., Голиусова М.Д., Ефремова О.С. Профилактика передачи ВИЧвдискордантных парах: информированность, осознание риска, поведение. Инфекционные болезни: новости, мнения, обучение 2021; 10(1): 46-51. https://doi.org/10.33029/2305-3496-2021-10-1-46-51